NewsSource: EClinCloud

EClinCloud Product Overview | eTMF · Trial Master File Management System

2 min readEClinCloud Editorial Team
Article image

Source: EClinCloud. Author: EClinCloud.

Article image



EClinCloud eTMF (electronic Trial Master File) is a professional electronic document management system primarily used to store, manage, and track clinical trial documents. It complies with GCP guidelines and follows FDA 21 CFR Part 11 standards to ensure data accuracy and integrity throughout a study. With EClinCloud eTMF, researchers can easily organize, retrieve, and share clinical trial documents, and regulatory authorities can efficiently conduct audits and inspections, improving study efficiency and ensuring study quality.


eTMF

One-Stop Product + Service Solution





1

What Does EClinCloud Offer?

1

eTMF System

2

System Training and Configuration Services

3

TMF Data Migration

4

TMF Management Framework

5

Global TMF Compliance Consulting


2

Features of EClinCloud eTMF

1

AI-enabled intelligent document content recognition and automatic classification

2

Convenient mobile support for scan-and-upload and smart recognition of non-standard documents

3

Flexible milestone-driven document filing to improve the success rate of TMF management

4

Multidimensional visual reports to analyze document management status



3

Why Choose EClinCloud eTMF?

Article image

EClinCloud eTMF is a leading system in China that meets global TMF regulatory compliance requirements

Backed by extensive domestic and international project experience and an in-depth understanding of document management regulations across different countries

Maintains the highest-level data management framework to safeguard the integrity and security of domestic and international data

EClinCloud eTMF interconnects with the CTMS system to enable efficient filing




About EClinCloud

EClinCloud is a technology company focused on clinical R&D that provides an integrated, interconnected, all-in-one clinical trial cloud platform (including technology products such as eCOA, CTMS, eTMF, EDC, RTSM, and RM, as well as solutions within those offerings such as scale design, scale copyright management, linguistic validation, rater training, and data quality analysis) and clinical trial endpoint assessment technologies across different therapeutic areas (including central nervous system and ophthalmology). Combining cutting-edge technology with life data, EClinCloud is building a globally leading "patient-centric" clinical evidence support SaaS cloud platform to help domestic and international pharmaceutical companies and research institutions improve R&D efficiency, accelerate the market launch of drugs and medical devices, and benefit countless patients.







Article image

Read original WeChat article

Related reading

WeChat image 2026-11-11_150855_109.pngNews6 min readWorld COPD Day | Imaging Assessment in COPD Clinical ResearchNovember 13-15, 2026. November 18, 2026 marks the 25 World COPD Day, with this year's theme: Early Diagnosis and Management for a Better Life. Chronic Obstructive Pulmonary Disease (COPD) is a preventable and treatable disease characterized by persistent airflow limitation. COPD is closely related to chronic bronchitis and emphysema [1]. We have previously covered COAs for COPD,Article imageNews3 min readAddressing Complex Challenges in Clinical Research: EClinCloud’s Full-Lifecycle AI Enablement Attracts AttentionFrom November 13–15, the 2026 Nucleic Acid Therapy and Intelligent Biomedicine Industry Innovation Conference, academically guided by the Chinese Stroke Association and hosted by the Yuanshu Brain Science Research Center, was held in Fuzhou. Dr. Qin Long, founder and CEO of EClinCloud, was invited to deliver a keynote speech titled “Practice and Application of AI in Clinical Research,” sharing insights on the development trends of AI-enabled new drug R&D and the practice of AI throughout the clinical research process, which attracted enthusiastic attention from the attending guests. 01 Current Landscape of AI-Enabled New Drug R&D: AI is demonstrating application value in multiple segments of new drug R&D, including target discoverySAPA-China 2026 CNS Forum on-site photo 1News3 min readFocusing on CNS Clinical Endpoint Assessment: EClinCloud Shares eCOA and IRC PracticesAt the CNS Forum of the SAPA-China 2026 Pharmaceutical Industry Conference, Zheng Liangyan, Medical Director at EClinCloud, shared approaches to applying eCOA and IRC, covering challenges, regulatory requirements, and practical implementation in central nervous system (CNS) disease clinical research.